bevacizumab plus chemotherapy

DRUG2 trials

Sponsors

Liaoning Cancer Hospital & Institute, Fudan University

Conditions

Colorectal CancerLiver Metastases

Phase 2

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Liaoning Cancer Hospital & InstituteColorectal Cancer, Liver Metastases

Start: 2012-09-30End: 2014-09-30Target: 100Updated: 2013-01-29

Phase 3

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Fudan UniversityColorectal Cancer

Start: 2018-06-01End: 2022-12-30Target: 78Updated: 2022-09-15

Related Papers

VIC regimen (vemurafenib/irinotecan/cetuximab) versus bevacizumab plus chemotherapy as first-line treatment for <i>BRAF</i> <i>V600E</i>-mutated advanced colorectal cancer.

Journal of Clinical Oncology2023-06-011 citations